{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T13:31:14Z","timestamp":1774359074843,"version":"3.50.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,5,14]],"date-time":"2015-05-14T00:00:00Z","timestamp":1431561600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12885-015-1409-4","type":"journal-article","created":{"date-parts":[[2015,5,13]],"date-time":"2015-05-13T12:53:24Z","timestamp":1431521604000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Identification of novel drugs to target dormant micrometastases"],"prefix":"10.1186","volume":"15","author":[{"given":"Robert E.","family":"Hurst","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul J.","family":"Hauser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youngjae","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lora C.","family":"Bailey-Downs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"Bastian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen M.","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Thorpe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Earle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilly Y. W.","family":"Bourguignon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Ihnat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,5,14]]},"reference":[{"issue":"24","key":"1409_CR1","doi-asserted-by":"publisher","first-page":"7519","DOI":"10.1158\/1078-0432.CCR-09-1068","volume":"15","author":"D Milojkovic","year":"2009","unstructured":"Milojkovic D, Apperley J. Mechanisms of resistance to imatinib and second-generation tyrosine inhibitors in chronic myeloid leukemia. Clin Cancer Res. 2009;15(24):7519\u201327.","journal-title":"Clin Cancer Res"},{"issue":"24","key":"1409_CR2","doi-asserted-by":"publisher","first-page":"7479","DOI":"10.1158\/1078-0432.CCR-09-0636","volume":"15","author":"PR Pohlmann","year":"2009","unstructured":"Pohlmann PR, Mayer IA, Mernaugh R. Resistance to trastuzumab in breast cancer. Clin Cancer Res. 2009;15(24):7479\u201391.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"1409_CR3","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.coph.2010.06.003","volume":"10","author":"PD Bos","year":"2010","unstructured":"Bos PD, Nguyen DX, Massague J. Modeling metastasis in the mouse. Curr Opin Pharmacol. 2010;10(5):571\u20137.","journal-title":"Curr Opin Pharmacol"},{"issue":"2","key":"1409_CR4","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.canlet.2012.09.025","volume":"328","author":"GF Weber","year":"2013","unstructured":"Weber GF. Why does cancer therapy lack effective anti-metastasis drugs? Cancer Lett. 2013;328(2):207\u201311.","journal-title":"Cancer Lett"},{"issue":"11","key":"1409_CR5","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"DF Quail","year":"2013","unstructured":"Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013;19(11):1423\u201337.","journal-title":"Nat Med"},{"issue":"8","key":"1409_CR6","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/nrc1670","volume":"5","author":"B Weigelt","year":"2005","unstructured":"Weigelt B, Peterse JL, Veer LJ V\u2019t. Breast cancer metastasis: markers and models. Nat Rev Cancer. 2005;5(8):591\u2013602.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"1409_CR7","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/S1535-6108(03)00167-3","volume":"4","author":"JW Gray","year":"2003","unstructured":"Gray JW. Evidence emerges for early metastasis and parallel evolution of primary and metastatic tumors. Cancer Cell. 2003;4(1):4\u20136.","journal-title":"Cancer Cell"},{"issue":"2","key":"1409_CR8","first-page":"249","volume":"3","author":"SW Melchior","year":"1997","unstructured":"Melchior SW, Corey E, Ellis WJ, Ross AA, Layton TJ, Oswin MM, et al. Early tumor cell dissemination in patients with clinically localized carcinoma of the prostate. Clin Cancer Res. 1997;3(2):249\u201356.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"1409_CR9","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.mbs.2009.11.006","volume":"223","author":"L Hanin","year":"2010","unstructured":"Hanin L, Korosteleva O. Does extirpation of the primary breast tumor give boost to growth of metastases? Evidence revealed by mathematical modeling. Math Bio sci. 2010;223(2):133\u201341.","journal-title":"Math Bio sci"},{"issue":"12","key":"1409_CR10","first-page":"1749","volume":"60","author":"L Simpson-Herren","year":"1976","unstructured":"Simpson-Herren L, Sanford AH, Holmquist JP. Effects of surgery on the cell kinetics of residual tumor. Cancer Treat Rep. 1976;60(12):1749\u201360.","journal-title":"Cancer Treat Rep"},{"issue":"2","key":"1409_CR11","first-page":"157","volume":"73","author":"RV Iozzo","year":"1995","unstructured":"Iozzo RV. Tumor stroma as a regulator of neoplastic behavior Agonistic and antagonistic elements embedded in the same connective tissue. Lab Invest. 1995;73(2):157\u201360.","journal-title":"Lab Invest"},{"issue":"23","key":"1409_CR12","doi-asserted-by":"publisher","first-page":"3640","DOI":"10.3748\/wjg.v11.i23.3640","volume":"11","author":"ZW Zhou","year":"2005","unstructured":"Zhou ZW, Rieger N, Ruszkiewicz A, Wang GQ, Wan DS. Detection of lymph nodes micrometastases in Dukes\u2019 A and B colorectal cancer using anti-cytokeratin antibodies AE1\/AE3. World J Gastroenterol. 2005;11(23):3640\u20133.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"1409_CR13","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/S0002-9440(10)65628-3","volume":"153","author":"KJ Luzzi","year":"1998","unstructured":"Luzzi KJ, MacDonald IC, Schmidt EE, Kerkvliet N, Morris VL, Chambers AF, et al. Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol. 1998;153(3):865\u201373.","journal-title":"Am J Pathol"},{"issue":"1","key":"1409_CR14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s10555-007-9103-x","volume":"27","author":"FC Bidard","year":"2008","unstructured":"Bidard FC, Pierga JY, Vincent-Salomon A, Poupon MF. A \u201cclass action\u201d against the microenvironment: do cancer cells cooperate in metastasis? Cancer Metastasis Rev. 2008;27(1):5\u201310.","journal-title":"Cancer Metastasis Rev"},{"issue":"4","key":"1409_CR15","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1593\/neo.08154","volume":"10","author":"AM Havens","year":"2008","unstructured":"Havens AM, Pedersen EA, Shiozawa Y, Ying C, Jung Y, Sun Y, et al. An in vivo mouse model for human prostate cancer metastasis. Neoplasia. 2008;10(4):371\u201380.","journal-title":"Neoplasia"},{"issue":"11","key":"1409_CR16","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/nrc2256","volume":"7","author":"JA Aguirre-Ghiso","year":"2007","unstructured":"Aguirre-Ghiso JA. Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer. 2007;7(11):834\u201346.","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"1409_CR17","first-page":"2162","volume":"62","author":"GN Naumov","year":"2002","unstructured":"Naumov GN, MacDonald IC, Weinmeister PM, Kerkvliet N, Nadkarni KV, Wilson SM, et al. Persistence of solitary mammary carcinoma cells in a secondary site: a possible contributor to dormancy. Cancer Res. 2002;62(7):2162\u20138.","journal-title":"Cancer Res"},{"issue":"2","key":"1409_CR18","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/joim.12084","volume":"274","author":"AJ Redig","year":"2013","unstructured":"Redig AJ, McAllister SS. Breast cancer as a systemic disease: a view of metastasis. J Intern Med. 2013;274(2):113\u201326.","journal-title":"J Intern Med"},{"issue":"2","key":"1409_CR19","doi-asserted-by":"publisher","first-page":"673","DOI":"10.2353\/ajpath.2006.060053","volume":"169","author":"M Suzuki","year":"2006","unstructured":"Suzuki M, Mose ES, Montel V, Tarin D. Dormant cancer cells retrieved from metastasis-free organs regain tumorigenic and metastatic potency. Am J Pathol. 2006;169(2):673\u201381.","journal-title":"Am J Pathol"},{"issue":"7","key":"1409_CR20","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.ejca.2010.02.027","volume":"46","author":"D Barkan","year":"2010","unstructured":"Barkan D, Green JE, Chambers AF. Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growth. Eur J Cancer. 2010;46(7):1181\u20138.","journal-title":"Eur J Cancer"},{"issue":"7","key":"1409_CR21","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1056\/NEJM199502163320704","volume":"332","author":"JA Brennan","year":"1995","unstructured":"Brennan JA, Mao L, Hruban RH, Boyle JO, Eby YJ, Koch WM, et al. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. NEngl J Med. 1995;332(7):429\u201335.","journal-title":"NEngl J Med"},{"issue":"2","key":"1409_CR22","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1158\/1078-0432.CCR-10-1369","volume":"17","author":"K Graham","year":"2011","unstructured":"Graham K, Ge X, de Las MA, Tripathi A, Rosenberg CL. Gene expression profiles of estrogen receptor-positive and estrogen receptor-negative breast cancers are detectable in histologically normal breast epithelium. Clin Cancer Res. 2011;17(2):236\u201346.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"1409_CR23","first-page":"641\u2013649","volume":"178","author":"RE Buller","year":"1998","unstructured":"Buller RE, Skilling JS, Sood AK, Plaxe S, Baergen RN, Lager DJ. Field cancerization: why late \u201crecurrent\u201d ovarian cancer is not recurrent. AmJObstetGynecol. 1998;178(4):641\u2013649\u2013642.","journal-title":"AmJObstetGynecol"},{"key":"1409_CR24","doi-asserted-by":"publisher","first-page":"8287","DOI":"10.1073\/pnas.90.17.8287","volume":"90","author":"JY Rao","year":"1993","unstructured":"Rao JY, Hemstreet GP, Hurst RE, Bonner RB, Jones PL, Min KW, et al. Alterations in phenotypic biochemical markers in bladder epithelium during tumorigenesis. Proc Natl Acad Sci USA. 1993;90:8287\u201391.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"1409_CR25","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.eururo.2004.07.012","volume":"47","author":"R Stoehr","year":"2005","unstructured":"Stoehr R, Zietz S, Burger M, Filbeck T, Denzinger S, Obermann EC, et al. Deletions of chromosomes 9 and 8p in histologically normal urothelium of patients with bladder cancer. Eur Urol. 2005;47(1):58\u201363.","journal-title":"Eur Urol"},{"issue":"10","key":"1409_CR26","doi-asserted-by":"publisher","first-page":"3694","DOI":"10.1158\/0008-5472.CAN-03-3264","volume":"64","author":"LC Chen","year":"2004","unstructured":"Chen LC, Hao CY, Chiu YS, Wong P, Melnick JS, Brotman M, et al. Alteration of gene expression in normal-appearing colon mucosa of APC(min) mice and human cancer patients. Cancer Res. 2004;64(10):3694\u2013700.","journal-title":"Cancer Res"},{"issue":"12","key":"1409_CR27","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/nrc2933","volume":"10","author":"PE Goss","year":"2010","unstructured":"Goss PE, Chambers AF. Does tumour dormancy offer a therapeutic target? Nat Rev Cancer. 2010;10(12):871\u20137.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"1409_CR28","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1023\/B:BREA.0000004377.12288.3c","volume":"82","author":"GN Naumov","year":"2003","unstructured":"Naumov GN, Townson JL, MacDonald IC, Wilson SM, Bramwell VH, Groom AC, et al. Ineffectiveness of doxorubicin treatment on solitary dormant mammary carcinoma cells or late-developing metastases. Breast Cancer Res Treat. 2003;82(3):199\u2013206.","journal-title":"Breast Cancer Res Treat"},{"issue":"15","key":"1409_CR29","doi-asserted-by":"publisher","first-page":"5337","DOI":"10.1158\/1078-0432.CCR-05-0437","volume":"11","author":"RJ Epstein","year":"2005","unstructured":"Epstein RJ. Maintenance therapy to suppress micrometastasis: the new challenge for adjuvant cancer treatment. Clin Cancer Res. 2005;11(15):5337\u201341.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"1409_CR30","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.canlet.2004.07.043","volume":"217","author":"RE Hurst","year":"2005","unstructured":"Hurst RE, Kamat CD, Kyker KD, Green DE, Ihnat MA. A novel multidrug resistance phenotype of bladder tumor cells grown on Matrigel or SIS gel. Cancer Lett. 2005;217(2):171\u201380.","journal-title":"Cancer Lett"},{"issue":"3","key":"1409_CR31","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1158\/1940-6207.CAPR-11-0046","volume":"4","author":"MM Taketo","year":"2011","unstructured":"Taketo MM. Reflections on the spread of metastasis to cancer prevention. Cancer Preven Res. 2011;4(3):324\u20138.","journal-title":"Cancer Preven Res"},{"issue":"4","key":"1409_CR32","first-page":"3119","volume":"23","author":"RE Hurst","year":"2003","unstructured":"Hurst RE, Kyker KD, Bonner RB, Bowditch RG, Hemstreet GP. Matrix-dependent plasticity of the malignant phenotype of bladder cancer cells. Anticancer Res. 2003;23(4):3119\u201328.","journal-title":"Anticancer Res"},{"issue":"5","key":"1409_CR33","doi-asserted-by":"publisher","first-page":"e64181","DOI":"10.1371\/journal.pone.0064181","volume":"8","author":"RE Hurst","year":"2013","unstructured":"Hurst RE, Hauser PJ, Kyker KD, Heinlen JE, Hodde JP, Hiles MC, et al. Suppression and activation of the malignant phenotype by extracellular matrix in xenograft models of bladder cancer: a model for tumor cell \u201cdormancy\u201d. PLoSOne. 2013;8(5):e64181.","journal-title":"PLoSOne"},{"issue":"2","key":"1409_CR34","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1089\/ten.1998.4.157","volume":"4","author":"SL Voytik-Harbin","year":"1998","unstructured":"Voytik-Harbin SL, Brightman AO, Waisner BZ, Robinson JP, Lamar CH. Small intestinal submucosa: a tissue-derived extracellular matrix that promotes tissue-specific growth and differentiation of cell in vitro. Tissue Eng. 1998;4(2):157\u201374.","journal-title":"Tissue Eng"},{"issue":"14","key":"1409_CR35","doi-asserted-by":"publisher","first-page":"5029","DOI":"10.1073\/pnas.84.14.5029","volume":"84","author":"RA Vescio","year":"1987","unstructured":"Vescio RA, Redfern CH, Nelson TJ, Ugoretz S, Stern PH, Hoffman RM. In vivo-like drug responses of human tumors growing in three-dimensional gel-supported primary culture. Proc Natl Acad Sci USA. 1987;84(14):5029\u201333.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"1409_CR36","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/0360-3016(79)90643-6","volume":"5","author":"RM Sutherland","year":"1979","unstructured":"Sutherland RM, Eddy HA, Bareham B, Reich K, Vanantwerp D. Resistance to adriamycin in multicellular spheroids. Int J Radiat Oncol Biol Phys. 1979;5(8):1225\u201330.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4949 Pt 1","key":"1409_CR37","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1126\/science.2108497","volume":"247","author":"BA Teicher","year":"1990","unstructured":"Teicher BA, Herman TS, Holden SA, Wang YY, Pfeffer MR, Crawford JW, et al. Tumor resistance to alkylating agents conferred by mechanisms operative only in vivo. Science. 1990;247(4949 Pt 1):1457\u201361.","journal-title":"Science"},{"issue":"39","key":"1409_CR38","doi-asserted-by":"publisher","first-page":"32800","DOI":"10.1074\/jbc.M111.308528","volume":"287","author":"LY Bourguignon","year":"2012","unstructured":"Bourguignon LY, Wong G, Earle C, Chen L. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma. J Biol Chem. 2012;287(39):32800\u201324.","journal-title":"J Biol Chem"},{"issue":"5","key":"1409_CR39","doi-asserted-by":"publisher","first-page":"e98624","DOI":"10.1371\/journal.pone.0098624","volume":"9","author":"LC Bailey-Downs","year":"2014","unstructured":"Bailey-Downs LC, Thorpe JE, Disch BC, Bastian A, Hauser PJ, Farasyn T, et al. Development and characterization of a preclinical model of breast cancer lung micrometastatic to macrometastatic progression. PLoS One. 2014;9(5):e98624.","journal-title":"PLoS One"},{"issue":"13","key":"1409_CR40","doi-asserted-by":"publisher","first-page":"5292","DOI":"10.1158\/0008-5472.CAN-09-1528","volume":"69","author":"AF Chambers","year":"2009","unstructured":"Chambers AF. MDA-MB-435 and M14 cell lines: identical but not M14 melanoma? Cancer Res. 2009;69(13):5292\u20133.","journal-title":"Cancer Res"},{"issue":"4","key":"1409_CR41","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.jmgm.2009.09.002","volume":"28","author":"MS Armstrong","year":"2009","unstructured":"Armstrong MS, Morris GM, Finn PW, Sharma R, Richards WG. Molecular similarity including chirality. J Mol Graph Model. 2009;28(4):368\u201370.","journal-title":"J Mol Graph Model"},{"issue":"9","key":"1409_CR42","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s10822-010-9374-0","volume":"24","author":"MS Armstrong","year":"2010","unstructured":"Armstrong MS, Morris GM, Finn PW, Sharma R, Moretti L, Cooper RI, et al. ElectroShape: fast molecular similarity calculations incorporating shape, chirality and electrostatics. J Comput Aided Mol Des. 2010;24(9):789\u2013801.","journal-title":"J Comput Aided Mol Des"},{"issue":"8","key":"1409_CR43","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s10822-011-9463-8","volume":"25","author":"MS Armstrong","year":"2011","unstructured":"Armstrong MS, Finn PW, Morris GM, Richards WG. Improving the accuracy of ultrafast ligand-based screening: incorporating lipophilicity into ElectroShape as an extra dimension. J Comput Aided Mol Des. 2011;25(8):785\u201390.","journal-title":"J Comput Aided Mol Des"},{"issue":"2","key":"1409_CR44","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.canlet.2006.08.017","volume":"249","author":"CD Kamat","year":"2007","unstructured":"Kamat CD, Green DE, Warnke L, Thorpe JE, Ceriello A, Ihnat MA. Mutant p53 facilitates pro-angiogenic, hyperproliferative phenotype in response to chronic relative hypoxia. Cancer Lett. 2007;249(2):209\u201319.","journal-title":"Cancer Lett"},{"issue":"20","key":"1409_CR45","doi-asserted-by":"publisher","first-page":"12281","DOI":"10.1074\/jbc.273.20.12281","volume":"273","author":"YL Zhang","year":"1998","unstructured":"Zhang YL, Keng YF, Zhao Y, Wu L, Zhang ZY. Suramin is an active site-directed, reversible, and tight-binding inhibitor of protein-tyrosine phosphatases. J Biol Chem. 1998;273(20):12281\u20137.","journal-title":"J Biol Chem"},{"issue":"1","key":"1409_CR46","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.1432-1033.1994.tb20022.x","volume":"226","author":"D Shiokawa","year":"1994","unstructured":"Shiokawa D, Ohyama H, Yamada T, Takahashi K, Tanuma S. Identification of an endonuclease responsible for apoptosis in rat thymocytes. Eur J Biochem FEBS. 1994;226(1):23\u201330.","journal-title":"Eur J Biochem FEBS"},{"issue":"20","key":"1409_CR47","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.2174\/138161207781039706","volume":"13","author":"E Nuti","year":"2007","unstructured":"Nuti E, Tuccinardi T, Rossello A. Matrix metalloproteinase inhibitors: new challenges in the era of post broad-spectrum inhibitors. Curr Pharm Des. 2007;13(20):2087\u2013100.","journal-title":"Curr Pharm Des"},{"issue":"10","key":"1409_CR48","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.4155\/fmc.14.68","volume":"6","author":"F Carta","year":"2014","unstructured":"Carta F, Supuran CT, Scozzafava A. Sulfonamides and their isosters as carbonic anhydrase inhibitors. Future Med Chem. 2014;6(10):1149\u201365.","journal-title":"Future Med Chem"},{"issue":"7222","key":"1409_CR49","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/nature07567","volume":"456","author":"E Quintana","year":"2008","unstructured":"Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM, Morrison SJ. Efficient tumour formation by single human melanoma cells. Nature. 2008;456(7222):593\u20138.","journal-title":"Nature"},{"issue":"10","key":"1409_CR50","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1634\/theoncologist.2012-0274","volume":"17","author":"AJ Combest","year":"2012","unstructured":"Combest AJ, Roberts PJ, Dillon PM, Sandison K, Hanna SK, Ross C, et al. Genetically engineered cancer models, but not xenografts, faithfully predict anticancer drug exposure in melanoma tumors. Oncologist. 2012;17(10):1303\u201316.","journal-title":"Oncologist"},{"issue":"3","key":"1409_CR51","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1124\/jpet.112.191957","volume":"341","author":"CC Wong","year":"2012","unstructured":"Wong CC, Cheng KW, Rigas B. Preclinical predictors of anticancer drug efficacy: critical assessment with emphasis on whether nanomolar potency should be required of candidate agents. J Pharmacol Exp Ther. 2012;341(3):572\u20138.","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"1409_CR52","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1186\/s13058-014-0407-9","volume":"16","author":"Q Cheng","year":"2014","unstructured":"Cheng Q, Chang JT, Gwin WR, Zhu J, Ambs S, Geradts J, et al. A signature of epithelial-mesenchymal plasticity and stromal activation in primary tumor modulates late recurrence in breast cancer independent of disease subtype. Breast Cancer Research BCR. 2014;16(4):407.","journal-title":"Breast Cancer Research BCR"},{"key":"1409_CR53","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/978-1-4614-1445-2_5","volume":"734","author":"MS Sosa","year":"2013","unstructured":"Sosa MS, Bragado P, Debnath J, Aguirre-Ghiso JA. Regulation of tumor cell dormancy by tissue microenvironments and autophagy. Adv Exp Med Biol. 2013;734:73\u201389.","journal-title":"Adv Exp Med Biol"},{"key":"1409_CR54","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/978-1-4614-1445-2_12","volume":"734","author":"L Hanin","year":"2013","unstructured":"Hanin L. Seeing the invisible: how mathematical models uncover tumor dormancy, reconstruct the natural history of cancer, and assess the effects of treatment. Adv Exp Med Biol. 2013;734:261\u201382.","journal-title":"Adv Exp Med Biol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-015-1409-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1409-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1409-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1409-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T07:37:50Z","timestamp":1551166670000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-015-1409-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,14]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1409"],"URL":"https:\/\/doi.org\/10.1186\/s12885-015-1409-4","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,14]]},"article-number":"404"}}